Strategic Research Institute G-Protein-Coupled Receptors Drug Discovery World Summit

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.13, Iss.8, 2004-08, pp. : 1071-1074

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

G_12/13-dependent signaling of G-protein-coupled receptors: disease context and impact on drug discovery

By Siehler Sandra

Expert Opinion on Drug Discovery, Vol. 2, Iss. 12, 2007-12 ,pp. : 1591-1604

Informa Healthcare

Access to resources Recommend Favorite

G-Protein-Coupled Receptors: New Approaches to Maximise the Impact of GPCRs in Drug Discovery

By Davey John

Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 2, 2004-04 ,pp. : 165-170

Informa Healthcare

Access to resources Recommend Favorite

Editorial [Hot Topic: G-Protein-Coupled Receptors (GPCRs) and Drug Discovery (Guest Editor: Luca Gentilucci)]

Current Drug Targets, Vol. 8, Iss. 1, 2007-01 ,pp. : 89-90

Bentham Science Publishers

Access to resources Recommend Favorite

Genetic variation in G-protein-coupled receptors – consequences for G-protein-coupled receptors as drug targets

By Tang Chih-Min Insel Paul A

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 6, 2005-12 ,pp. : 1247-1265

Informa Healthcare

Access to resources Recommend Favorite

Fragment-based lead discovery on G-protein-coupled receptors

By Visegrády András

Expert Opinion on Drug Discovery, Vol. 8, Iss. 7, 2013-08 ,pp. : 811-820

Informa Healthcare

Access to resources Recommend Favorite